Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. (clinicaltrials.gov) - Sep 26, 2026 - P2 | N=150 | Recruiting | Sponsor: M.D. Anderson Cancer Center | N=50 ➔ 150
Enrollment change • Chronic Myeloid Leukemia • Hematological Malignancies • Leukemia • Oncology • ABL1
|